CHARACTERIZATION OF HUMAN PAPILLOMAVIRUS VACCINES: THE WORLD EXPERIENCE
Persistence of high risk human papillomavirus (HPV) genotypes is the leading cause of cervical cancer, as well as anogenital and oropharyngeal cancers. This article focuses on analysis of the global use of the licensed HPV vaccines, given the introduction of HPV vaccination into national immunization programs of many countries. All vaccines are safe, immunogenic and eﬀective in population usage, with the most frequent adverse event being injection site reactions.